Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1991 Mar;67(785):291–294. doi: 10.1136/pgmj.67.785.291

Alopecia totalis and vitiligo in common variable immunodeficiency.

G Spickett 1, A G Prentice 1, T Wallington 1, A D Webster 1, H Chapel 1
PMCID: PMC2399007  PMID: 2062780

Abstract

Three cases of severe and irreversible alopecia occurring in patients with common variable immunodeficiency are described. In all three cases, hair loss developed after the diagnosis of immune deficiency; one of the patients also had extensive vitiligo. A fourth patient had vitiligo in the absence of alopecia. No change in the alopecia or vitiligo was noted in any patient as a result of immunoglobulin replacement therapy.

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amornsiripanitch S., Barnes L. M., Nordlund J. J., Trinkle L. S., Rheins L. A. Immune studies in the depigmenting C57BL/Ler-vit/vit mice. An apparent isolated loss of contact hypersensitivity. J Immunol. 1988 May 15;140(10):3438–3445. [PubMed] [Google Scholar]
  2. Bor S., Feiwel M., Chanarin I. Vitiligo and its aetiological relationship to organ-specific autoimmune disease. Br J Dermatol. 1969 Feb;81(2):83–88. doi: 10.1111/j.1365-2133.1969.tb15985.x. [DOI] [PubMed] [Google Scholar]
  3. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol. 1989 Jan;9(1):22–33. doi: 10.1007/BF00917124. [DOI] [PubMed] [Google Scholar]
  4. Duvic M., Rapini R., Hoots W. K., Mansell P. W. Human immunodeficiency virus-associated vitiligo: expression of autoimmunity with immunodeficiency? J Am Acad Dermatol. 1987 Oct;17(4):656–662. doi: 10.1016/S0190-9622(87)70252-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fiedler-Weiss V. C., Buys C. M. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation. Br J Dermatol. 1987 Dec;117(6):759–763. doi: 10.1111/j.1365-2133.1987.tb07357.x. [DOI] [PubMed] [Google Scholar]
  6. García M. C., Fonseca E., Pascual D., Gontán G., de la Concha E. G., Arnalich F., Ojeda J. A. Hipogammaglobulinemia primaria y alopecia areata. Med Clin (Barc) 1983 May 7;80(16):717–719. [PubMed] [Google Scholar]
  7. Hertz K. C., Gazze L. A., Kirkpatrick C. H., Katz S. I. Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med. 1977 Sep 22;297(12):634–637. doi: 10.1056/NEJM197709222971204. [DOI] [PubMed] [Google Scholar]
  8. Ipp M. M., Gelfand E. W. Antibody deficiency and alopecia. J Pediatr. 1976 Nov;89(5):728–731. doi: 10.1016/s0022-3476(76)80791-3. [DOI] [PubMed] [Google Scholar]
  9. Korkij W., Soltani K., Simjee S., Marcincin P. G., Chuang T. Y. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cutan Pathol. 1984 Dec;11(6):522–530. doi: 10.1111/j.1600-0560.1984.tb00413.x. [DOI] [PubMed] [Google Scholar]
  10. Lamont S. J., Smyth J. R., Jr Effect of bursectomy on development of a spontaneous postnatal amelanosis. Clin Immunol Immunopathol. 1981 Dec;21(3):407–411. doi: 10.1016/0090-1229(81)90229-4. [DOI] [PubMed] [Google Scholar]
  11. Leen C. L., Birch A. D., Brettle R. P., Welsby P. D., Yap P. L. Salmonellosis in patients with primary hypogammaglobulinaemia. J Infect. 1986 May;12(3):241–245. doi: 10.1016/s0163-4453(86)94216-7. [DOI] [PubMed] [Google Scholar]
  12. McGregor B. C., Katz H. I., Doe R. P. Vitiligo and multiple glandular insufficiencies. JAMA. 1972 Feb;219(6):724–725. [PubMed] [Google Scholar]
  13. Morrell D., Chase C. L., Kupper L. L., Swift M. Diabetes mellitus in ataxia-telangiectasia, Fanconi anemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families. Diabetes. 1986 Feb;35(2):143–147. doi: 10.2337/diab.35.2.143. [DOI] [PubMed] [Google Scholar]
  14. Naughton G. K., Eisinger M., Bystryn J. C. Antibodies to normal human melanocytes in vitiligo. J Exp Med. 1983 Jul 1;158(1):246–251. doi: 10.1084/jem.158.1.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Naughton G. K., Reggiardo D., Bystryn J. C. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):978–981. doi: 10.1016/s0190-9622(86)70260-0. [DOI] [PubMed] [Google Scholar]
  16. Norris D. A., Kissinger R. M., Naughton G. M., Bystryn J. C. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol. 1988 Jun;90(6):783–789. doi: 10.1111/1523-1747.ep12461505. [DOI] [PubMed] [Google Scholar]
  17. Nunzi E., Hamerlinck F., Cormane R. H. Immunopathological studies on alopecia areata. Arch Dermatol Res. 1980;269(1):1–11. doi: 10.1007/BF00404452. [DOI] [PubMed] [Google Scholar]
  18. Spickett G. P., Webster A. D., Farrant J. Cellular abnormalities in common variable immunodeficiency. Immunodefic Rev. 1990;2(3):199–219. [PubMed] [Google Scholar]
  19. Tan R. S. Thymoma, acquired hypogammaglobulinaemia, lichen planus, alopecia areata. Proc R Soc Med. 1974 Mar;67(3):196–198. doi: 10.1177/003591577406700309. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES